This may result in the promotion of tumorigenesis and tumor progression by facilitating tumor-associated platelet activation, and the presence of RGS18 in the tumor may contribute to sustained blood platelet concentration through its transfer to hematopoietic stem cells. The gene discussed is RGS18; the disease is neoplasm.